angiotensin II type 2 & 4 inhibiting agent

^[1]

Pathology

initiation of antihypertensive medications that stimulate vs inhibit type 2 & 4 angiotensin II receptors may result in a lower risk of dementia^[1]

↑ ^1.0 ^1.1 Anderseon P Some BP Meds Tied to Significantly Lower Risk for Dementia, Alzheimer's. Medscape. Jan 20, 2023 https://www.medscape.com/viewarticle/986775
Marcum ZA, Gabriel N, Bress AP et al Association of New Use of Antihypertensives That Stimulate vs Inhibit Type 2 and 4 Angiotensin II Receptors With Dementia Among Medicare Beneficiaries. JAMA Netw Open. 2023;6(1):e2249370. PMID: https://www.ncbi.nlm.nih.gov/pubmed/36598787 https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2800004